MTI 100 Review: Medtechs Drive To Keep The Status Quo In A Year Like No Other
Medtech Insight's review of the industry's leading companies' revenue performances in 2020 kicks off our 2022 Outlook Analysis
The performances of the leading medtechs in the first year of the COVID pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management's planning skills.
